Author Profile

Written By

Jonathan Taylor

Director, Marketing & Development

Latest Content from Jonathan Taylor

May 24, 2019

Nonalcoholic steatohepatitis (NASH): Connections driving emerging market innovation

The scope of drug discovery research has grown immensely in recent decades. Previously uncharted areas of discovery continue to emerge sparking inspiration and focus for scientists, organizations and even countries as a whole. One such research area that has gained momentum over the last 10 years is nonalcoholic steatohepatitis (NASH). NASH describes inflammation and damage of the liver caused by a buildup of fat. NASH is estimated to impact as much as 12% of the US population and is expected to become the leading cause of liver transplantation by 2020.

August 24, 2018

It's not just a haystack anymore: Why research leaders must prioritize information resource strategy to drive innovation

February 23, 2018

Which countries take the gold in the research winter games?